AVR · Anteris Technologies Global Corp. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 |
|---|---|---|---|---|---|
| Revenue | $494.0K | - | $769.0K | $618.0K | $766.0K |
| Cost of Revenue | $114.0K | - | $123.0K | $312.0K | $473.0K |
| Gross Profit | $380.0K | - | $646.0K | $306.0K | $293.0K |
| R&D | $17.46M | - | $16.81M | $12.63M | $11.56M |
| SG&A | $6.93M | - | $6.98M | $5.01M | $6.52M |
| Total Operating Expenses | - | - | - | - | - |
| D&A | $429.0K | - | - | - | $345.0K |
| Operating Income | ($24.01M) | - | ($22.27M) | ($20.88M) | ($17.79M) |
| Interest Expense | $27.0K | - | $11.0K | $22.0K | $17.0K |
| Income Tax | $492.0K | - | $0 | $0 | $0 |
| Net Income | ($23.02M) | - | ($22.24M) | ($18.71M) | ($16.35M) |
| EPS - Basic | ($0.28) | - | ($0.62) | ($0.58) | ($0.91) |
| EPS - Diluted | ($0.28) | - | ($0.62) | ($0.58) | ($0.91) |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 |
|---|---|---|---|---|---|
| Cash & Equivalents | $283.21M | $12.58M | $9.12M | $7.18M | $70.46M |
| Accounts Receivable | $231.0K | $32.0K | $234.0K | $687.0K | $208.0K |
| Inventory | $122.0K | $152.0K | $436.0K | $449.0K | $513.0K |
| Accounts Payable | $3.79M | $11.09M | $4.28M | $5.40M | $5.89M |
| Current Assets | $286.67M | $15.68M | $11.22M | $32.21M | $74.65M |
| Total Assets | $294.72M | $23.00M | $19.07M | $39.88M | $58.79M |
| Current Liabilities | $13.69M | $21.37M | $13.43M | $13.34M | $16.56M |
| Long-term Debt | - | - | - | - | - |
| Total Liabilities | $16.31M | $23.25M | $15.71M | $15.85M | $18.02M |
| Stockholders' Equity | $278.44M | ($93.0K) | $3.70M | $24.41M | $43.26M |
| Retained Earnings | ($393.56M) | ($370.53M) | ($341.33M) | ($319.09M) | ($298.25M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 |
|---|---|---|---|---|---|
| Operating Cash Flow | ($28.68M) | - | - | - | ($15.53M) |
| Investing Cash Flow | ($182.0K) | - | - | - | ($717.0K) |
| Financing Cash Flow | $299.51M | - | - | - | $1.55M |
| CapEx | $137.0K | - | - | - | $717.0K |
| Free Cash Flow | ($28.82M) | - | - | - | ($16.25M) |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 |
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 76.9% | - | 84.0% | 49.5% | 38.3% |
| Operating margin | -4859.7% | - | -2895.3% | -3379.3% | -2321.8% |
| EBITDA margin | -4772.9% | - | - | - | -2276.8% |
| Net margin | -4660.7% | - | -2892.6% | -3027.0% | -2134.5% |
| Free cash flow margin | -5833.4% | - | - | - | -2121.3% |
| FCF / Net income | 1.25 | - | - | - | 0.99 |
| R&D / Revenue | 3533.8% | - | 2186.0% | 2044.3% | 1508.6% |
| SG&A / Revenue | 1402.8% | - | 907.3% | 811.3% | 851.4% |
| Effective tax rate | - | - | - | - | - |
| Return on assets | -7.8% | - | -116.6% | -46.9% | -27.8% |
| Return on equity | -8.3% | - | -601.5% | -76.6% | -37.8% |
| Return on invested capital | - | - | - | - | - |
| Liquidity | |||||
| Current ratio | 20.93 | 0.73 | 0.84 | 2.41 | 4.51 |
| Quick ratio | 20.93 | 0.73 | 0.80 | 2.38 | 4.48 |
| Cash ratio | 20.68 | 0.59 | 0.68 | 0.54 | 4.25 |
| Leverage | |||||
| Debt / Equity | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - |
| Interest coverage | -889.1x | - | -2024.1x | -949.3x | -1046.2x |
| Equity multiplier | 1.06 | -247.28 | 5.16 | 1.63 | 1.36 |
| Liabilities / Assets | 0.06 | 1.01 | 0.82 | 0.40 | 0.31 |
| Efficiency | |||||
| Asset turnover | 0.00 | - | 0.04 | 0.02 | 0.01 |
| Inventory turnover | 0.93 | - | 0.28 | 0.69 | 0.92 |
| Days sales outstanding | 171d | - | 111d | 406d | 99d |
| Days inventory outstanding | 391d | - | 1294d | 525d | 396d |
| Days payable outstanding | 12135d | - | 12689d | 6315d | 4544d |
| Cash conversion cycle | -11573d | - | -11284d | -5384d | -4049d |
| Valuation | |||||
| P / E | - | - | - | - | - |
| P / B | 1.7x | - | 25.0x | 5.6x | 1.5x |
| P / S | 932.6x | - | 120.0x | 221.2x | 85.0x |
| EV / EBITDA | - | - | - | - | - |
| Growth | |||||
| Revenue growth (YoY) | -35.5% | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - |
| Gross profit growth (YoY) | 29.7% | - | - | - | - |
| Operating income growth (YoY) | -35.0% | - | - | - | - |
| Net income growth (YoY) | -40.8% | - | - | - | - |
| EPS growth (YoY) | 69.2% | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - |
| FCF growth (YoY) | -77.3% | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - |
| Book value growth (YoY) | 543.7% | - | - | - | - |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$1.91M totalAnteris Business Segment$1.91M · 100.0%
Geographic
$1.91M totalUS$1.61M · 84.1%
DE$272.0K · 14.2%
AU$33.0K · 1.7%
Peer comparison
Same SIC group: Orthopedic, Prosthetic & Surgical Appliances & Supplies
Comparing Anteris Technologies Global Corp. against the 5 most active filers in the same SIC group.